Logo
17.05.2019

Article

The Top 10 Largest Pharmaceutical Mergers in History

The pharmaceutical industry is under pressure. The sales and profits of the pharmaceutical giants have been declining for years. As a way out of this misery, takeovers and mergers seem to be a tried and tested means. PharmaTEC and PROCESS summarise the largest deals in the histor...

read...
Logo
10.05.2019

Article

Pfizer Acquires Biotech Company Therachon

Pfizer has entered into a definitive agreement to acquire all the shares of Therachon, a privately-held clinical-stage biotechnology company focused on rare diseases. Under the terms of the agreement, the US-company will pay $ 340 million upfront with an additional $ 470 million ...

read...
Logo
10.05.2019

Article

Pfizer Acquires Biotech Company Therachon

Pfizer has entered into a definitive agreement to acquire all the shares of Therachon, a privately-held clinical-stage biotechnology company focused on rare diseases. Under the terms of the agreement, the US-company will pay $ 340 million upfront with an additional $ 470 million ...

read...
Logo
10.09.2018

Article

Pfizer Prices $ 5 Billion Debt Offering

Pfizer announced the pricing of a debt offering consisting of six tranches of notes with a total volume of $ 5 billion.

read...
Logo
26.07.2018

Article

Pfizer to Invest Nearly Half a Billion Dollars in Sterile Injectable Facility

Pfizer is investing $ 465 million to build a technically advanced sterile injectable pharmaceutical production facility in Portage, Michigan.

read...
Logo
26.07.2018

Article

Pfizer to Invest Nearly Half a Billion Dollars in Sterile Injectable Facility

Pfizer is investing $ 465 million to build a technically advanced sterile injectable pharmaceutical production facility in Portage, Michigan.

read...
Logo
16.11.2017

Article

Pfizer Sells 49 % of its JV Equity Shares

The company has sold its shares in its joint venture, Hisun-Pfizer Pharmaceuticals, to Sapphire I (HK) Holdings. Post the transfer, the joint venture will retain its current rights to manufacture, sell and distribute the company’s products in China.

read...
Logo
16.10.2017

Article

Pfizer Announces Strategic Restructuring of its Healthcare Businesses

Pfizer said that a range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.

read...
Logo
12.10.2017

Article

Pfizer Announces Strategic Restructuring of its Healthcare Businesses

Pfizer said that a range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.

read...
Logo
12.10.2017

Article

Pfizer Announces Strategic Restructuring of its Healthcare Businesses

Pfizer said that a range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.

read...
Logo
28.06.2017

Article

Pfizer Expands Global R&D Network

Pfizer broke ground on a state-of-the art Research and Development (R&D) and process development facility in Chesterfield, MO. The new campus will be owned by the biopharmaceutical company and will bring together more than 450 employees who currently work at multiple location...

read...
Logo
01.07.2016

Article

Top 10 Mergers and Acquisitions – Chemicals and Pharmaceuticals Industry Gets the Knives Out

2015 was the year of mergers and acquisitions (M&A). Mergers and acquisitions increased by 43 % worldwide to a new record value of 4.5 billion dollars as compared to the previous year. PROCESS presents the biggest deals of the previous 18 months in detail.

read...
Logo
01.12.2014

Article

Pfizer Completes Acquisition of Baxter’s Marketed Vaccines

Pfizer announced that it has completed the acquisition of Baxter International´s portfolio of marketed vaccines, which consists of Neis Vac-C and FSME-Immun/Tico Vac. As previously reported, Pfizer also acquired a portion of Baxter’s facility in Orth, Austria, where these vaccine...

read...
Logo
18.07.2014

Article

Pfizer to Acquire Innopharma

Pfizer and Innopharma today announced that they have entered into an agreement under which Pfizer will acquire Innopharma. Under the terms of the agreement, Pfizer will acquire Innopharma for an upfront cash payment of $225 million, with up to $135 million of contingent milestone...

read...
Logo
21.05.2014

Article

Astra Zeneca Brushes Off Pfizer Offer

It could have been the world’s biggest takeover in pharmaceuticals ever: Pfizer has placed a € 85 million bid for Astra Zeneca. But it seems that the Brits met Pfizer’s advances with a rebuff.

read...